IL2 and psoriasis: In conclusion, xenografting of lesional skin from psoriasis patients onto human IL-2 NOG mice resulted in improved human T-cell activity in the grafts, systemic presence of human T-cells and increased disease relevant human cytokine levels in both grafts and serum compared to C.B-17 SCID and NOG mice.